Carregant...
The Minority Report: Targeting the Rare Oncogenes in NSCLC
Lung cancer is still responsible for the highest number of cancer deaths worldwide. Despite this fact, significant progress has been made in the treatment of non-small cell lung cancer (NSCLC). Specifically, efforts to identify and treat genetic alterations (gene mutations, gene fusions, gene amplif...
Guardat en:
| Publicat a: | Curr Treat Options Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4216615/ https://ncbi.nlm.nih.gov/pubmed/25228144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-014-0310-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|